Navigation Links
Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
Date:3/21/2011

Solutions 100

Vical Strengthens Angiogenesis and Poloxamers IPR Portfolio 100

Biomira Takes Over ProIX Pharmaceuticals 100

FDA Gives Out Warning on Bevacizumab Drug 101

Athenagen Merges with Zapaq 101

Tigris Secures Global Licensing Rights to Develop and

Commercialize New Cancer Therapies 101

Bayer Yakuhin Files Marketing Application for Nexavar in Japan 101

Athenagen Purchases Assets of Osprey Pharmaceutical 102

Amgen Acquires Abgenix 102

Genmab Enters Exclusive Licensing Agreement with Bionomics 102

OSI Pharmaceuticals Acquires Eyetech Pharmaceuticals 103

FDA Changes Labeling of Iressa, Limiting Use to NSCLC 103

Schering AG and Novartis Signs a Agreement to Commercialize

Angiogenesis Inhibitor, PTK787 103

Bausch & Lomb Signs an Option Agreement with PTC Therapeutics 104

Bausch & Lomb Receives License from Cephalon, Inc 104

Pharmacopeia Signs a Licensing Agreement with Allergan 104

Xantos Biomedicine and Cryptome Enters into Licensing Agreement 104

EntreMed Receives US Patent 105

FDA Issues Warning on Risks Associated with Bevacizumab 105

Compound Therapeutics Acquires Strategic Assets of Phylos 105

Sanofi Announces Plans to Acquire Aventis 105

ThromboGenics Enters into Collaborative Agreement with

Geymonat S.p.A. 105

AngioGenex Signs Development and Marketing Agreement with

BioCheck 106

Progen Industries Limited Bags Orphan Drug Status from US FDA 106

Regeneron Pharmaceuticals Initiates Phase I Clinical Trials

in Cancer 106

Roche Group to Undertake Expansion Program 106

Regeneron and Aventis Initiate a Clinical Development Program 106

EntreMed Signs Licensing Agreement with Celgene Corporation 106

Progen Industries Limited Receives EU Patent 107

Phylonix Pharmaceuticals Bags Phase II SBIR Grant 107

10. FOCUS ON SELE
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Tronics, a designer ... & Marketing Director. , With more than 25 years of experience in ... Tronics’ business development activities worldwide. He brings to the company his strong expertise ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
(Date:7/30/2015)...  With over 60,000 customers across the globe, ISN improves the efficiency and effectiveness ... more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In ... Headquartered in Dallas, TX , ISN has additional ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... ... Ranked Based on Patent Quality, Not Quantity , ... Chicago, IL (PRWeb) January 19, 2010-- Ocean Tomo, LLC, ... performed for Bloomberg BusinessWeek. , , , , ,The study, which ranks the 25 ...
... COLUMBIA, S.C. , Jan. 19 ... University of South Carolina,s Jones Physical Science Center, ... experiments. , The 33,000-square-foot project included the renovation of 11,000 ... Research, which was established in 2002 by the Center for ...
... NANTONG CITY, China , ... "Sinobiopharma" or the "Company"), a fully,integrated and highly innovative biopharmaceutical ... pharmaceutical products,in China , today announced financial results for ... Second Quarter 2010 Highlights, ...
Cached Biology Technology:Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 2Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 3Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 4Hendrick Construction Renovates USC Science Building 2Sinobiopharma Announces Second Quarter 2010 Financial Results 2Sinobiopharma Announces Second Quarter 2010 Financial Results 3Sinobiopharma Announces Second Quarter 2010 Financial Results 4
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... 30, 2015 Research ... addition of the "Capacitive Fingerprint Sensors Patent ... To this date, fingerprint sensing technology is the ... sensors are well developed. This patent landscape focuses ... The domain of capacitive fingerprint sensors is ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... (January 5, 2011) The Jackson Laboratory (JAX), Sackler School of ... Medicine have unveiled a new mammalian genetics track for PhD ... at both JAX and Tufts. Combining the faculty and resources ... human disease, and the faculty and resources at JAX, with ...
... , Walter and Eliza Hall Institute researchers in Melbourne, ... viruses evade early detection by the immune system. Their ... able to establish chronic infections, leading scientists to reevaluate ... from the institute,s Immunology division together with collaborators at ...
... 5, 2010) The University of Texas Health Science ... first Phase I safety study approved by the Food ... child,s own umbilical cord blood stem cells for traumatic ... in conjunction with Children,s Memorial Hermann Hospital, UTHealth,s primary ...
Cached Biology News:Jackson Laboratory and Tufts University announce new Ph.D. track in mammalian genetics 2Viral evasion gene reveals new targets for eliminating chronic infections 2UTHealth studies cord blood stem cells for pediatric traumatic brain injury 2
Mouse monoclonal antibody raised against a partial recombinant VRK2. NCBI Entrez Gene ID = VRK2...
Mouse monoclonal antibody raised against a partial recombinant L3MBTL2. NCBI Entrez Gene ID = L3MBTL2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
... a partial recombinant IFNA2. Immunogen: ... is produced in E. coli. The biological ... OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...
Biology Products: